Literature DB >> 14662434

Identification and high-resolution mapping of a constitutional 11q deletion in an infant with multifocal neuroblastoma.

Yael Mosse1, Joel Greshock, Allison King, Deepa Khazi, Barbara L Weber, John M Maris.   

Abstract

Entities:  

Mesh：

Year:  2003        PMID： 14662434     DOI： 10.1016/s1470-2045(03)01283-x

Source DB:  PubMed          Journal:  Lancet Oncol        ISSN： 1470-2045            Impact factor:   41.316


× No keyword cloud information.
  9 in total

1.  Constitutional 3p26.3 terminal microdeletion in an adolescent with neuroblastoma.

Authors:  Annalisa Pezzolo; Angela Rita Sementa; Margherita Lerone; Martina Morini; Marzia Ognibene; Raffaella Defferrari; Katia Mazzocco; Massimo Conte; Anna Rita Gigliotti; Alberto Garaventa; Vito Pistoia; Luigi Varesio
Journal:  Cancer Biol Ther       Date:  2017-04-12       Impact factor: 4.742

2.  Germline 16p11.2 Microdeletion Predisposes to Neuroblastoma.

Authors:  Laura E Egolf; Zalman Vaksman; Gonzalo Lopez; Jo Lynne Rokita; Apexa Modi; Patricia V Basta; Hakon Hakonarson; Andrew F Olshan; Sharon J Diskin
Journal:  Am J Hum Genet       Date:  2019-08-29       Impact factor: 11.025

Review 3.  Genetic susceptibility to neuroblastoma.

Authors:  Vanessa P Tolbert; Grace E Coggins; John M Maris
Journal:  Curr Opin Genet Dev       Date:  2017-04-28       Impact factor: 5.578

Review 4.  Genetic susceptibility to neuroblastoma: current knowledge and future directions.

Authors:  Laura E Ritenour; Michael P Randall; Kristopher R Bosse; Sharon J Diskin
Journal:  Cell Tissue Res       Date:  2018-03-27       Impact factor: 5.249

5.  Positional and functional mapping of a neuroblastoma differentiation gene on chromosome 11.

Authors:  Katleen De Preter; Jo Vandesompele; Björn Menten; Philippa Carr; Heike Fiegler; Anders Edsjö; Nigel P Carter; Nurten Yigit; Wim Waelput; Nadine Van Roy; Scott Bader; Sven Påhlman; Frank Speleman
Journal:  BMC Genomics       Date:  2005-07-06       Impact factor: 3.969

6.  Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes.

Authors:  Katleen De Preter; Jo Vandesompele; Pierre Heimann; Nurten Yigit; Siv Beckman; Alexander Schramm; Angelika Eggert; Raymond L Stallings; Yves Benoit; Marleen Renard; Anne De Paepe; Geneviève Laureys; Sven Påhlman; Frank Speleman
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

Review 7.  11q deletion in neuroblastoma: a review of biological and clinical implications.

Authors:  Vid Mlakar; Simona Jurkovic Mlakar; Gonzalo Lopez; John M Maris; Marc Ansari; Fabienne Gumy-Pause
Journal:  Mol Cancer       Date:  2017-06-29       Impact factor: 27.401

8.  CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23.

Authors:  Evi Michels; Jasmien Hoebeeck; Katleen De Preter; Alexander Schramm; Bénédicte Brichard; Anne De Paepe; Angelika Eggert; Geneviève Laureys; Jo Vandesompele; Frank Speleman
Journal:  BMC Cancer       Date:  2008-06-17       Impact factor: 4.430

9.  Ataxia-telangiectasia mutated (ATM) silencing promotes neuroblastoma progression through a MYCN independent mechanism.

Authors:  Stefano J Mandriota; Linda J Valentijn; Laurence Lesne; David R Betts; Denis Marino; Mary Boudal-Khoshbeen; Wendy B London; Anne-Laure Rougemont; Edward F Attiyeh; John M Maris; Michael D Hogarty; Jan Koster; Jan J Molenaar; Rogier Versteeg; Marc Ansari; Fabienne Gumy-Pause
Journal:  Oncotarget       Date:  2015-07-30
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.